Stock listing
HROW Stock Price, News, Filings & Events — Harrow, Inc.
Selected listing: HROW · NASDAQ · USD · US
This page tracks Harrow, Inc.'s HROW:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HROW:NASDAQ. HROW:NASDAQ is the stock-level entry point for investors researching Harrow, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Harrow, Inc. (ticker: HROW) is a public company based in the United States with a market capitalization of approximately $1.43 billion. The company focuses on the development and commercialization of innovative pharmaceutical products. Harrow aims to enhance patient care through its specialized offerings in the healthcare sector.
- Ticker
- HROW:NASDAQ
- Asset type
- Stock
- Market cap
- $1.40B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Harrow, Inc. HROW:NASDAQ stock context
This page tracks Harrow, Inc.'s HROW:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HROW:NASDAQ. HROW:NASDAQ is the stock-level entry point for investors researching Harrow, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Harrow, Inc. (ticker: HROW) is a public company based in the United States with a market capitalization of approximately $1.43 billion. The company focuses on the development and commercialization of innovative pharmaceutical products. Harrow aims to enhance patient care through its specialized offerings in the healthcare sector.
Latest news from Harrow, Inc.
Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections
August 20, 2026
Harrow Announces Second Quarter 2026 Financial Results
August 10, 2026
Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026
July 27, 2026
Harrow Highlights Growing Clinical Evidence Supporting IHEEZO® and BYOOVIZ® at ASRS 2026 Annual Meeting
July 20, 2026
Harrow Announces Commercial Launch of BYOOVIZ® in the United States
July 1, 2026
Harrow, Inc. earnings calls
Harrow, Inc. (HROW) Q2 2026 Earnings Call
August 11, 2026 · Replay with transcript and chapters
Harrow, Inc. (HROW) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Harrow, Inc. (HROW) Q4 2025 Earnings Call
March 3, 2026 · Replay with transcript and chapters
Harrow, Inc. (HROW) Q3 2025 Earnings Call
November 11, 2025 · Replay with transcript and chapters
Harrow, Inc. (HROW) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Harrow, Inc. (HROW) Q1 2025 Earnings Call
May 9, 2025 · Replay with transcript and chapters
Research Harrow, Inc.
Harrow, Inc. investor report
Review AI stock analysis and investor report context for HROW:NASDAQ.
Harrow, Inc. company profile
View the public company page for Harrow, Inc. on 6ix.
Harrow, Inc. news
Read company news and market updates connected to Harrow, Inc..
Harrow, Inc. investor events
Find investor webinars, events, and replay context for Harrow, Inc..